|
Volumn 22, Issue 3, 2008, Pages 261-272
|
Review and clinical perspectives for the use of infliximab in ulcerative colitis
|
Author keywords
Drug administration schedule; Immunomodulatory agents; Inflammatory bowel disease; Infliximab; Monoclonal antibodies; Ulcerative colitis
|
Indexed keywords
ANTIDIARRHEAL AGENT;
AZATHIOPRINE;
BETAMETHASONE;
CORTICOSTEROID;
CYCLOSPORIN;
GLUCOCORTICOID;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
METHYLPREDNISOLONE;
PARACETAMOL;
PLACEBO;
PREDNISOLONE;
SALAZOSULFAPYRIDINE;
STEROID;
SULFAMETHOXAZOLE;
TRIMETHOPRIM;
APLASTIC ANEMIA;
CHILL;
CLINICAL TRIAL;
COLON RESECTION;
COUGHING;
CROHN DISEASE;
DELAYED HYPERSENSITIVITY;
DEMYELINATION;
DISEASE SEVERITY;
DIZZINESS;
DRUG CONTRAINDICATION;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FEVER;
DRUG HYPERSENSITIVITY;
DRUG INDICATION;
DRUG INDUCED HEADACHE;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
DYSPNEA;
ENDOSCOPY;
HEPATITIS;
HISTOPLASMOSIS;
HUMAN;
IMMUNOTHERAPY;
INFECTION RISK;
LYMPHOPROLIFERATIVE DISEASE;
MAINTENANCE THERAPY;
MORTALITY;
PANCYTOPENIA;
POLYNEUROPATHY;
PRIORITY JOURNAL;
PRURITUS;
RECOMMENDED DRUG DOSE;
REMISSION;
REVIEW;
RISK ASSESSMENT;
STEROID THERAPY;
THORAX PAIN;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
TUBERCULOSIS;
ULCERATIVE COLITIS;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
VASCULITIS;
|
EID: 43549098033
PISSN: 08357900
EISSN: None
Source Type: Journal
DOI: 10.1155/2008/493405 Document Type: Review |
Times cited : (10)
|
References (86)
|